BACKGROUND: Current echocardiographic guidelines recommend that tricuspid regurgitation (TR) severity be graded in three categories, following assessment of specific parameters. Findings from recent trials have shown that the severity of TR frequently far exceeds the current definition of severe. We postulated that a grading approach that emphasizes outcomes could be useful to identify patients with severe TR at increased risk of mortality. METHODS: We identified 284 patients with echocardiograms demonstrating severe functional TR, defined as vena contracta (VC) ≥ 0.7 cm. Demographics and mortality data were obtained from the medical records. Patients were divided into study (n = 122 patients with three-dimensional images) and validation (n = 162) cohorts. The VC was measured in both the right ventricular (RV) inflow and apical four-chamber views and averaged. For the study cohort, tricuspid annular, RV end-diastolic (basal, mid, long axis) dimensions, tricuspid leaflet tenting height and area, RV free-wall longitudinal strain, and RV volumes were measured from two- and three-dimensional data sets. A K-partition algorithm was used in the study cohort to derive a mortality-related cutoff VC value, above which TR was termed "massive." The ability of this VC cutoff to identify patients at greater mortality risk was then tested in the validation cohort using Kaplan-Meier survival analysis. RESULTS: In the study cohort, VC > 0.92 cm (massive TR) was optimally associated with worse survival. Tricuspid annular and RV size were larger in the massive group (P < .05), while there were no significant differences in demographics between the TR groups. Importantly, in the independent validation cohort, the above VC cutoff also correlated with increased mortality in the massive group (log-rank P < .05). CONCLUSIONS: Among patients traditionally defined as having severe TR, a subset exists with massive TR, resulting in greater adverse RV remodeling and increased mortality. These patients may derive the greatest benefit from emerging percutaneous therapies.
BACKGROUND: Current echocardiographic guidelines recommend that tricuspid regurgitation (TR) severity be graded in three categories, following assessment of specific parameters. Findings from recent trials have shown that the severity of TR frequently far exceeds the current definition of severe. We postulated that a grading approach that emphasizes outcomes could be useful to identify patients with severe TR at increased risk of mortality. METHODS: We identified 284 patients with echocardiograms demonstrating severe functional TR, defined as vena contracta (VC) ≥ 0.7 cm. Demographics and mortality data were obtained from the medical records. Patients were divided into study (n = 122 patients with three-dimensional images) and validation (n = 162) cohorts. The VC was measured in both the right ventricular (RV) inflow and apical four-chamber views and averaged. For the study cohort, tricuspid annular, RV end-diastolic (basal, mid, long axis) dimensions, tricuspid leaflet tenting height and area, RV free-wall longitudinal strain, and RV volumes were measured from two- and three-dimensional data sets. A K-partition algorithm was used in the study cohort to derive a mortality-related cutoff VC value, above which TR was termed "massive." The ability of this VC cutoff to identify patients at greater mortality risk was then tested in the validation cohort using Kaplan-Meier survival analysis. RESULTS: In the study cohort, VC > 0.92 cm (massive TR) was optimally associated with worse survival. Tricuspid annular and RV size were larger in the massive group (P < .05), while there were no significant differences in demographics between the TR groups. Importantly, in the independent validation cohort, the above VC cutoff also correlated with increased mortality in the massive group (log-rank P < .05). CONCLUSIONS: Among patients traditionally defined as having severe TR, a subset exists with massive TR, resulting in greater adverse RV remodeling and increased mortality. These patients may derive the greatest benefit from emerging percutaneous therapies.
Authors: Patrizio Lancellotti; Luis Moura; Luc A Pierard; Eustachio Agricola; Bogdan A Popescu; Christophe Tribouilloy; Andreas Hagendorff; Jean-Luc Monin; Luigi Badano; Jose L Zamorano Journal: Eur J Echocardiogr Date: 2010-05
Authors: Ken J Lu; Janet X C Chen; Konstantinos Profitis; Leighton G Kearney; Dimuth DeSilva; Gerard Smith; Michelle Ord; Susan Harberts; Paul Calafiore; Elizabeth Jones; Piyush M Srivastava Journal: Echocardiography Date: 2014-10-07 Impact factor: 1.724
Authors: Yan Topilsky; Vuyisile T Nkomo; Ori Vatury; Hector I Michelena; Thierry Letourneau; Rakesh M Suri; Sorin Pislaru; Soon Park; Douglas W Mahoney; Simon Biner; Maurice Enriquez-Sarano Journal: JACC Cardiovasc Imaging Date: 2014-11-05
Authors: J P Sun; K B James; X S Yang; N Solankhi; M S Shah; K L Arheart; J D Thomas; W J Stewart Journal: Am J Cardiol Date: 1997-12-15 Impact factor: 2.778
Authors: Rebecca T Hahn; Christopher U Meduri; Charles J Davidson; Scott Lim; Tamim M Nazif; Mark J Ricciardi; Vivek Rajagopal; Gorav Ailawadi; Mani A Vannan; James D Thomas; Dale Fowler; Stuart Rich; Randy Martin; Geraldine Ong; Adam Groothuis; Susheel Kodali Journal: J Am Coll Cardiol Date: 2017-04-11 Impact factor: 24.094
Authors: Maurizio Taramasso; Rebecca T Hahn; Hannes Alessandrini; Azeem Latib; Adrian Attinger-Toller; Daniel Braun; Eric Brochet; Kim A Connelly; Paolo Denti; Florian Deuschl; Andrea Englmaier; Neil Fam; Christian Frerker; Joerg Hausleiter; Jean-Michel Juliard; Ryan Kaple; Felix Kreidel; Karl Heinz Kuck; Shingo Kuwata; Marco Ancona; Margarita Malasa; Tamim Nazif; Georg Nickenig; Fabian Nietlispach; Alberto Pozzoli; Ulrich Schäfer; Joachim Schofer; Robert Schueler; Gilbert Tang; Alec Vahanian; John G Webb; Ermela Yzeiraj; Francesco Maisano; Martin B Leon Journal: JACC Cardiovasc Interv Date: 2017-10-09 Impact factor: 11.195
Authors: Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367
Authors: Jan A Krikken; Ad F M van den Heuvel; H Marco Willemsen; Adriaan A Voors; Erik Lipsic Journal: Neth Heart J Date: 2022-03-29 Impact factor: 2.854